曲妥珠单抗-德鲁替康在 HER2 低表达乳腺癌中有效。
Trastuzumab Deruxtecan Is Effective in HER2-Low Breast Cancer.
出版信息
Cancer Discov. 2020 Apr;10(4):488. doi: 10.1158/2159-8290.CD-RW2020-030. Epub 2020 Feb 28.
Abstract
The anti-HER2-drug conjugate trastuzumab deruxtecan (T-DXd) was effective in HER2-low breast cancer.
摘要
抗 HER2 药物偶联物曲妥珠单抗 deruxtecan（T-DXd）在 HER2 低表达乳腺癌中有效。
Zotero 插件